| Revenue |
Schedule
of revenue
| | |
2026 | | |
2025 | | |
2024 | |
| | |
USD | | |
USD | | |
USD | |
| | |
| | |
| | |
| |
| Revenue from contracts with customers: | |
| | | |
| | | |
| | |
| Cellular therapy | |
| 883,016 | | |
| 586,440 | | |
| 407,443 | |
| Medical testing, laboratory and aesthetics beauty services | |
| 3,149,193 | | |
| 2,617,110 | | |
| 1,755,910 | |
| Consultation fee | |
| 92,331 | | |
| 157,467 | | |
| 232,173 | |
| Sale of medicine and healthcare product | |
| 731,780 | | |
| 10,020 | | |
| 8,026 | |
| | |
| | | |
| | | |
| | |
| Revenue from contracts with customer | |
| 4,856,320 | | |
| 3,371,037 | | |
| 2,403,552 | |
| | |
| | | |
| | | |
| | |
| Timing of revenue recognition: | |
| | | |
| | | |
| | |
| At a point in time | |
| 4,856,320 | | |
| 3,371,037 | | |
| 2,403,552 | |
|